Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Chevron
CVX
|
+$331M |
| 2 |
Walmart
WMT
|
+$229M |
| 3 |
Linde
LIN
|
+$187M |
| 4 |
PayPal
PYPL
|
+$145M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$903M |
| 2 |
Uber
UBER
|
+$565M |
| 3 |
Exxon Mobil
XOM
|
+$450M |
| 4 |
Novo Nordisk
NVO
|
+$393M |
| 5 |
Apple
AAPL
|
+$317M |
Sector Composition
| 1 | Technology | 18.82% |
| 2 | Healthcare | 17.05% |
| 3 | Consumer Discretionary | 13.22% |
| 4 | Financials | 8.79% |
| 5 | Consumer Staples | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Predictive Oncology
POAI
$10.3M
| $44K | ﹤0.01% |
17,176
+3,000
| +21% | +$7.69K |
|
|
QNRX
3502
Quoin Pharmaceuticals
QNRX
$4.36M
| $44K | ﹤0.01% |
+1,329
| New | +$44K |
|
|
VIOT
3503
Viomi Technology
VIOT
$226M
| $44K | ﹤0.01% |
81,864
+1,100
| +1% | +$591 |
|
3504
Cyclacel Pharmaceuticals
CYCC
$15.2M
| $44K | ﹤0.01% |
87
+27
| +45% | +$13.7K |
|
3505
Alpha Tau Medical
DRTS
$319M
| $43K | ﹤0.01% |
14,700
-9,900
| -40% | -$29K |
|
3506
MAIA Biotechnology
MAIA
$51.5M
| $42K | ﹤0.01% |
19,000
-92,200
| -83% | -$204K |
|
3507
Azitra
AZTR
$4.17M
| $41K | ﹤0.01% |
+998
| New | +$41K |
|
3508
Envoy Medical
COCH
$27.3M
| $41K | ﹤0.01% |
+10,555
| New | +$41K |
|
|
PW
3509
Power REIT
PW
$3.36M
| $41K | ﹤0.01% |
54,296
+297
| +0.6% | +$224 |
|
|
CONN
3510
DELISTED
Conn's Inc.
CONN
| $41K | ﹤0.01% |
12,112
-7,200
| -37% | -$24.4K |
|
3511
Bitcoin Depot
BTM
$258M
| $40K | ﹤0.01% |
+21,300
| New | +$40K |
|
3512
Perfect Corp
PERF
$190M
| $40K | ﹤0.01% |
16,100
+2,100
| +15% | +$5.22K |
|
3513
P3 Health Partners
PIII
$28.4M
| $40K | ﹤0.01% |
776
-2,264
| -74% | -$117K |
|
3514
SPAR Group
SGRP
$27.7M
| $40K | ﹤0.01% |
41,100
+2,100
| +5% | +$2.04K |
|
|
PGRU
3515
DELISTED
PropertyGuru Group Limited
PGRU
| $40K | ﹤0.01% |
+10,456
| New | +$40K |
|
|
FRZA
3516
DELISTED
Forza X1, Inc. Common Stock
FRZA
| $40K | ﹤0.01% |
84,400
+34,200
| +68% | +$16.2K |
|
|
NBSE
3517
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $40K | ﹤0.01% |
88,229
+31,262
| +55% | +$14.2K |
|
|
SLI
3518
Standard Lithium
SLI
$582M
| $39K | ﹤0.01% |
33,100
-49,045
| -60% | -$57.8K |
|
3519
Exicure
XCUR
$23.6M
| $39K | ﹤0.01% |
13,120
+3,220
| +33% | +$9.57K |
|
|
HYZN
3520
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $39K | ﹤0.01% |
+1,059
| New | +$39K |
|
3521
Advent Technologies
ADN
$7.88M
| $38K | ﹤0.01% |
6,967
-2,446
| -26% | -$13.3K |
|
3522
Perspective Therapeutics
CATX
$240M
| $38K | ﹤0.01% |
3,175
-27,500
| -90% | -$329K |
|
3523
DSS Inc
DSS
$11.3M
| $38K | ﹤0.01% |
21,148
+1,315
| +7% | +$2.36K |
|
3524
Focus Universal
FCUV
$19.1M
| $38K | ﹤0.01% |
9,381
+8,110
| +638% | +$32.9K |
|
3525
Polar Power
POLA
$5.63M
| $38K | ﹤0.01% |
9,899
+429
| +5% | +$1.65K |
|